- Conditions
- Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), Cardiovascular Diseases, +29 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
CLL (Chronic Lymphocytic Leukemia)
Explore clinical trials studying CLL (Chronic Lymphocytic Leukemia). Study availability and eligibility vary by location and protocol.
15 public trials
6 recruiting studies
CLL (Chronic Lymphocytic Leukemia) trial results
Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
NCT07671378
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
NCT07342478
- Conditions
- CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more
- Locations
-
- The Center for Cancer and Blood Disorders-Bethesda Bethesda, Maryland, United States
- Optum Medical Group (Rhodes) P.C. Las Vegas, Nevada, United States
- OSU Comprehensive Cancer Center Columbus, Ohio, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Recruiting
CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL
NCT07487428
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Klinikum der Technischen Universität München (Klinikum rechts der Isar) München, Bavaria, Germany
- Conditions
- AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Stanford Palo Alto, California, United States
- University of Miami Miami, Florida, United States
NCT06708897
- Conditions
- CLL (Chronic Lymphocytic Leukemia), CLL / SLL, Chronic Disease, +16 more
- Locations
-
- Norton Cancer Institute, St. Matthews Campus Louisville, Kentucky, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- The Ohio State University Columbus, Ohio, United States
Not Yet Recruiting
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
NCT07710781
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
- Locations
-
Not specified
NCT07624799
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL
NCT06979076
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Chronic Disease, Disease Attributes, +15 more
- Locations
-
Not specified
Completed
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
NCT01145209
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Chronic Disease, Disease Attributes, +15 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States